BOOM
Recent additions may not be included but will usually appear in 24 hrs or less.
| Rational | Source |
|---|---|
|
Effect of <i>Lactobacillus rhamnosus</i> HN001 and <i>Bifidobacterium longum</i> BB536 on the healthy gut microbiota composition at phyla and species level: A preliminary study. ✅
Go to Publication ✅
World journal of gastroenterology (World J Gastroenterol ) Vol: 23 Issue 15 Pages: 2696-2704 Pub: 2017 Apr 21 Epub: Authors Toscano M , De Grandi R , Stronati L , De Vecchi E , Drago L , |
|
|
Effect of <i>Lactobacillus rhamnosus</i> HN001 and <i>Bifidobacterium longum</i> BB536 on the healthy gut microbiota composition at phyla and species level: A preliminary study. ✅
Go to Publication ✅
World journal of gastroenterology (World J Gastroenterol ) Vol: 23 Issue 15 Pages: 2696-2704 Pub: 2017 Apr 21 Epub: Authors Toscano M , De Grandi R , Stronati L , De Vecchi E , Drago L , |
|
|
Effect of Lactobacillus rhamnosus hsryfm 1301 on the Gut Microbiota and Lipid Metabolism in Rats Fed a High-Fat Diet. ✅
Journal of microbiology and biotechnology (J Microbiol Biotechnol ) Vol: 25 Issue 5 Pages: 687-95 Pub: 2015 May Epub: Authors Chen D , Yang Z , Chen X , Huang Y , Yin B , Guo F , Zhao H , Huang J , Wu Y , Gu R , |
|
|
Effect of Lactobacillus rhamnosus hsryfm 1301 on the Gut Microbiota and Lipid Metabolism in Rats Fed a High-Fat Diet. ✅
Journal of microbiology and biotechnology (J Microbiol Biotechnol ) Vol: 25 Issue 5 Pages: 687-95 Pub: 2015 May Epub: Authors Chen D , Yang Z , Chen X , Huang Y , Yin B , Guo F , Zhao H , Huang J , Wu Y , Gu R , |
|
|
Limosilactobacillus reuteri and Lacticaseibacillus rhamnosus GG differentially affect gut microbes and metabolites in mice with Treg-deficiency. ✅
Go to Publication ✅
American journal of physiology. Gastrointestinal and liver physiology (Am J Physiol Gastrointest Liver Physiol ) Vol: Issue Pages: Pub: 2021 Mar 31 Epub: 2021 Mar 31 Authors Liu Y , Hoang TK , Taylor CM , Park ES , Freeborn J , Luo M , Roos S , Rhoads JM , |
|
|
Lactobacillus rhamnosus GG Ameliorated Long-Term Exposure to TiO(2) Nanoparticles Induced Microbiota-Mediated Liver and Colon Inflammation and Fructose-Caused Metabolic Abnormality in Metabolism Syndrome Mice. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 69 Issue 34 Pages: 9788-9799 Pub: 2021 Sep 1 Epub: 2021 Aug 12 Authors Zhao Y , Liu S , Tang Y , You T , Xu H , |
|
|
Comparative Evaluation of the Inhibitory Effect of Lactobacillus rhamnosus on Halitosis-Causing Bacteria: An Invitro Microbiological Study. ✅
Go to Publication ✅
Cureus (Cureus ) Vol: 15 Issue 5 Pages: e38568 Pub: 2023 May Epub: 2023 May 5 Authors Patil AV , Shetty SS , Padhye AM , |
|
|
Lacticaseibacillus rhamnosus HN001 alters the microbiota composition in the cecum but not the feces in a piglet model. ✅
Go to Publication ✅
Frontiers in nutrition (Front Nutr ) Vol: 9 Issue Pages: 1002369 Pub: 2022 Epub: 2022 Oct 28 Authors Young W , Maclean P , Dunstan K , Ryan L , Peters J , Armstrong K , Anderson R , Dewhurst H , van Gendt M , Dilger RN , Dekker J , Haggarty N , Roy N , |
|
|
A neurotherapeutic approach with Lacticaseibacillus rhamnosus E9 on gut microbiota and intestinal barrier in MPTP-induced mouse model of Parkinson's disease. ✅
Go to Publication ✅
Scientific reports (Sci Rep ) Vol: 14 Issue 1 Pages: 15460 Pub: 2024 Jul 4 Epub: 2024 Jul 4 Authors Aktas B , Aslim B , Ozdemir DA , |
|
|
Lacticaseibacillus rhamnosus-Derived Exopolysaccharide Attenuates D-Galactose-Induced Oxidative Stress and Inflammatory Brain Injury and Modulates Gut Microbiota in a Mouse Model. ✅
Go to Publication ✅
Microorganisms (Microorganisms ) Vol: 10 Issue 10 Pages: Pub: 2022 Oct 17 Epub: 2022 Oct 17 Authors Kumari M , Dasriya VL , Nataraj BH , Nagpal R , Behare PV , |
|
|
Uremia-Induced Gut Barrier Defect in 5/6 Nephrectomized Mice Is Worsened by Candida Administration through a Synergy of Uremic Toxin, Lipopolysaccharide, and (1?3)-ß-D-Glucan, but Is Attenuated by Lacticaseibacillus rhamnosus L34. ✅
Go to Publication ✅
International journal of molecular sciences (Int J Mol Sci ) Vol: 23 Issue 5 Pages: Pub: 2022 Feb 24 Epub: 2022 Feb 24 Authors Tungsanga S , Panpetch W , Bhunyakarnjanarat T , Udompornpitak K , Katavetin P , Chancharoenthana W , Chatthanathon P , Somboonna N , Tungsanga K , Tumwasorn S , Leelahavanichkul A , |
|
|
Lactobacillus rhamnosus Attenuates Cisplatin-Induced Intestinal Mucositis in Mice via Modulating the Gut Microbiota and Improving Intestinal Inflammation. ✅
Go to Publication ✅
Pathogens (Basel, Switzerland) (Pathogens ) Vol: 12 Issue 11 Pages: Pub: 2023 Nov 11 Epub: 2023 Nov 11 Authors Alsholi DM , Yacoub GS , Rehman AU , Ullah H , Khan AI , Deng T , Siddiqui NZ , Alioui Y , Farooqui NA , Elkharti M , Li Y , Wang L , Xin Y , |
|
|
Lactobacillus rhamnosus GG ATCC53103 and Lactobacillus plantarum JL01 improved nitrogen metabolism in weaned piglets by regulating the intestinal flora structure and portal vein metabolites. ✅
Go to Publication ✅
Frontiers in microbiology (Front Microbiol ) Vol: 14 Issue Pages: 1200594 Pub: 2023 Epub: 2023 Jun 29 Authors He F , Jin X , Wang C , Hu J , Su S , Zhao L , Geng T , Zhao Y , Pan L , Bao N , Sun H , |
|
|
Lactobacillus rhamnosus TR08 Improves Dyslipidemia in Mice Fed with a High Fat Diet by Regulating the Intestinal Microbiota, Reducing Systemic Inflammatory Response, and Promoting Sphingomholipid Metabolism. ✅
Go to Publication ✅
Molecules (Basel, Switzerland) (Molecules ) Vol: 27 Issue 21 Pages: Pub: 2022 Oct 29 Epub: 2022 Oct 29 Authors Feng X , Ding L , Ma G , Zhang Y , Sun Y , Li Z , Tao X , Ali A , Wang D , Wu L , |
|
|
Adjunctive Probiotic Lactobacillus rhamnosus Probio-M9 Administration Enhances the Effect of Anti-PD-1 Antitumor Therapy via Restoring Antibiotic-Disrupted Gut Microbiota. ✅
Go to Publication ✅
Frontiers in immunology (Front Immunol ) Vol: 12 Issue Pages: 772532 Pub: 2021 Epub: 2021 Dec 14 Authors Gao G , Ma T , Zhang T , Jin H , Li Y , Kwok LY , Zhang H , Sun Z , |
|
|
Lactobacillus rhamnosus LRa05 Ameliorate Hyperglycemia through a Regulating Glucagon-Mediated Signaling Pathway and Gut Microbiota in Type 2 Diabetic Mice. ✅
Go to Publication ✅
Journal of agricultural and food chemistry (J Agric Food Chem ) Vol: 69 Issue 31 Pages: 8797-8806 Pub: 2021 Aug 11 Epub: 2021 Aug 2 Authors Wu T , Zhang Y , Li W , Zhao Y , Long H , Muhindo EM , Liu R , Sui W , Li Q , Zhang M , |
|
|
Lactobacillus rhamnosus from human breast milk ameliorates ulcerative colitis in mice via gut microbiota modulation. ✅
Go to Publication ✅
Food & function (Food Funct ) Vol: 12 Issue 11 Pages: 5171-5186 Pub: 2021 Jun 8 Epub: Authors Pang B , Jin H , Liao N , Li J , Jiang C , Shao D , Shi J , |
|
|
Clinical Efficacy of Probiotics for Allergic Rhinitis: Results of an Exploratory Randomized Controlled Trial. ✅
Go to Publication ✅
Nutrients (Nutrients ) Vol: 16 Issue 23 Pages: Pub: 2024 Nov 30 Epub: 2024 Nov 30 Authors Lungaro L , Malfa P , Manza F , Costanzini A , Valentini G , Squarzanti DF , Viciani E , Velichevskaya A , Castagnetti A , Barbalinardo M , Gentili D , Cariani A , Ghisellini S , Caputo F , De Giorgio R , Caio G , |
|
|
Lacticaseibacillus rhamnosus Fmb14 prevents purine induced hyperuricemia and alleviate renal fibrosis through gut-kidney axis. ✅
Go to Publication ✅
Pharmacological research (Pharmacol Res ) Vol: 182 Issue Pages: 106350 Pub: 2022 Aug Epub: 2022 Jul 14 Authors Zhao H , Chen X , Zhang L , Meng F , Zhou L , Pang X , Lu Z , Lu Y , |
|
|
Lacticaseibacillus rhamnosus LRa05 alleviates cyclophosphamide-induced immunosuppression and intestinal microbiota disorder in mice. ✅
Go to Publication ✅
Journal of food science (J Food Sci ) Vol: 89 Issue 12 Pages: 10003-10017 Pub: 2024 Dec Epub: 2024 Nov 26 Authors Zhu M , Yang L , Kong S , Bai Y , Zhao B , |
|
|
Lacticaseibacillus rhamnosus LRa05 alleviates cyclophosphamide-induced immunosuppression and intestinal microbiota disorder in mice. ✅
Go to Publication ✅
Journal of food science (J Food Sci ) Vol: 89 Issue 12 Pages: 10003-10017 Pub: 2024 Dec Epub: 2024 Nov 26 Authors Zhu M , Yang L , Kong S , Bai Y , Zhao B , |
BOOM
All suggestions are computed solely on their predicted microbiome impact. Safety, side-effects etc must be evaluated by your medical professionals before starting. Some items suggests have significant risk of adverse consequences for some people.
Special thanks to David F Morrison and Geert Van Houcke for doing Quality Assurance. Special thanks to Oliver Luk, B.Sc. (Biology) from BiomeSight for spot checking the coding of data from the US National Library of Medicine
This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.
Copyright 2016-2023 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 § 1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.
Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.
